News

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...
The report provides several stakeholders, including fruit manufacturers, farmers, fruit processors, distributors, retailers, ...